2019 American Transplant Congress
Non-Immunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
*Purpose: In kidney transplantation, non-immunologic donor-recipient (D-R) pairing is generally not given the same consideration as immunologic matching. The aim of this study was to…2019 American Transplant Congress
Protocol Cardiac Cathaterization in Renal Transplant Candidates
*Purpose: Appropriate cardiac evaluation prior to kidney transplantation is controversial. The following retrospective analysis was performed to evaluate the value of performing cardiac catheterization on…2019 American Transplant Congress
Non-HLA Antibodies against Structural and Non-Structural Target in C4d Negative Antibody Mediated Rejections after Renal Transplantation
*Purpose: According to the latest Banff’s criteria approved in 2003, antibody mediated rejections following renal transplantation are divided into 2 types namely C4d + and…2019 American Transplant Congress
De Novo Belatacept to Delay Tacrolimus Initiation in Renal Transplants with Delayed Graft Function
Medical City Fort Worth Transplant Institute, Fort Worth, TX
*Purpose: Delayed graft function (DGF) post renal transplant (RT) is associated with adverse patient and graft outcomes. Early tacrolimus (FK) initiation with high trough levels…2019 American Transplant Congress
Can Financial Incentives Improve Patient Compliance with Optn Live Kidney Donor Follow-Up Policy? Results of a Randomized Controlled Trial
*Purpose: The Organ Procurement and Transplantation Network (OPTN) requires transplant hospitals to monitor live kidney donors (LKDs) for 2 years post-donation. However, the majority (57%)…2019 American Transplant Congress
Surgical Outcome and Analysis of Risk of Complications in Kidney Donors Receiving Laparoscopic Live Donor Nephrectomy
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
*Purpose: Laparoscopic live donor nephrectomy has adopted for more than 20 years. But the operative procedure is still technically demanding, and allows almost no margin…2019 American Transplant Congress
Regeneration of Kidney with a Novel Biomimetic Vascular Scaffold
*Purpose: Appropriate vascularization is one of the most important issues to be addressed in the clinical application of 3D bioengineered organ.*Methods: We have fabricated biomimetic…2019 American Transplant Congress
When to Hold: Apixaban in Renal Transplant Recipients
1Yale New Haven Hospital, New Haven, CT, 2Yale School of Medicine, New Haven, CT
*Purpose: Renal transplant recipients (RTRs) may develop deep venous thrombosis (DVT), pulmonary embolism (PE), or atrial fibrillation requiring treatment with oral anticoagulation. There is limited…2019 American Transplant Congress
Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients
1University of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH
*Purpose: High tacrolimus (TAC) intrapatient variability (IPV) is associated with poorer outcomes. Manual monitoring of TAC IPV is labor intensive and not always feasible. As…2019 American Transplant Congress
Utilization of Hepatitis C Donors is Safe and Cost Effective
*Purpose: The use of hepatitis C (hep C) positive donors has become increasingly attractive with the advent of improved curative pharmacologic treatments. As a result…
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 101
- Next Page »